Last updated 2026-10-29
Portfolio
6
in our dataset
Rounds participated
9
Rounds led
4
Rounds' value
$238.5M
total disclosed, rounds participated
Stages
Pre-Seed, Seed, Series A, Series B, Series C, Growth, Late Stage, Pre-IPO, Buyout
About
Arkin Capital (formerly Arkin Holdings) is a leading multi-asset investment manager with over $2.5 billion under management. Founded in 2009 by Mori Arkin, the firm has expanded its expertise from life sciences and health investments to include technology, private equity, and real estate. Arkin Capital operates through four main investment arms: Arkin Health, Arkin Equity, Arkin Tech, and Arkin Real Estate. They invest in early to late-stage companies across various sectors, including biotech, digital health, and technology, with a focus on innovative solutions and high-growth potential.
Portfolio · 6
Phytolon
Phytolon develops and produces natural food colors using precision fermentation of baker's yeast.
Honeycomb Insurance
Digital insurer specializing in apartment buildings and condo associations, leveraging AI for precise underwriting.
Percepto
Percepto provides autonomous drone technology and industrial inspection solutions, powered by robotics and AI.
Salignostics
Salignostics is an Israeli startup developing accessible, rapid, and reliable saliva-based diagnostic solutions.
MedMinder Systems Inc.
MedMinder provides smart pill dispensers and a connected pharmacy care solution for medication management.
BioSight
Developer of therapeutics for oncology & hematological disorders.
Q&A
- What is Arkin Holdings' total Assets Under Management (AUM)?
- Arkin Holdings, operating as Arkin Capital, manages over $2 billion in assets across various investment vehicles.
- What are Arkin Holdings' primary investment sectors?
- Arkin Holdings focuses on four core areas: Health (biotech, digital health), Equity (private equity, Israeli public markets), Tech (diversified technology), and Real Estate. Their preferred sectors include Life Sciences, High Tech, and Medical Devices.
- What is Arkin Holdings' typical check size for investments?
- Arkin Holdings typically invests between $3 million and $20 million per company.
- Which investment funds has Arkin Holdings launched recently?
- Arkin Holdings launched Arkin Opportunity in 2023. Prior to that, they launched Arkin Bio-Capital and Arkin Digital Health Fund II in 2021.
- What is the focus of Arkin Holdings' recent fund, Arkin Bio Ventures III?
- Arkin Bio Ventures III, launched in 2026 with a size of $100 million, focuses on biotech and life sciences investments, consistent with Arkin Holdings' strong emphasis on healthcare.
- Who are the key partners at Arkin Holdings?
- Key partners at Arkin Holdings include Mori Arkin (Founder & Chairman), Nir Arkin (CEO, Partner), Dr. Pini Orbach (Managing Partner, Arkin Bio), and Nadav Shimoni (Partner).
- When was Arkin Holdings founded and where is it headquartered?
- Arkin Holdings was founded in 2009 by Mori Arkin and is headquartered in Herzliya, Israel.
- What is Arkin Holdings' investment thesis?
- Arkin Holdings invests in areas of deep expertise, partnering with visionary founders of early-stage companies with potential to disrupt industries, and accelerating life-changing therapies. They leverage extensive cross-sector exposure to support portfolio companies.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | arkin-capital.com |
|---|---|
| linkedin.com/company/arkin-capital |
Identifiers & details
| Legal name | Arkin Holdings Ltd |
|---|---|
| Founded | 2009 |